For the year ending 2025-12-31, NAGE made $129,423K in revenue. $17,382K in net income. Net profit margin of 13.43%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Sales, net | 129,423 | |||
| Cost of sales | 46,234 | |||
| Gross profit | 83,189 | |||
| Sales and marketing | 35,506 | |||
| Research and development | 6,330 | |||
| General and administrative | 27,057 | |||
| Gain on settlement of royalty obligation | 1,983 | |||
| Total operating expenses, net | 66,910 | |||
| Operating income | 16,279 | |||
| Investment income, interest | 2,127 | |||
| Irs ertc disallowance | -214 | |||
| Total nonoperating income, net | 1,913 | |||
| Income before provision for income taxes | 18,192 | |||
| Provision for income taxes | 810 | |||
| Net income | 17,382 | |||
| Basic EPS | 0.22 | |||
| Diluted EPS | 0.2 | |||
| Basic Average Shares | 79,178,000 | |||
| Diluted Average Shares | 85,436,000 | |||
Niagen Bioscience, Inc. (NAGE)
Niagen Bioscience, Inc. (NAGE)